Levin, Frances Rudnick
- Phoenix Pharmalabs, Inc. (no department on record)
- New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #1,720
- Program Leader
- Top 10% Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2001 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$3.1M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#1,720
By linked amount among FY2023 PIs
Earliest Year Loaded
2001
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Levin, Frances Rudnick as a PI. Multi-PI records show the full award amount for context.
- 5U01DA057862-02U01Contact PIDevelopment of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder$2.4Maward amount
- 1UG3DA056138-01A1UG3Contact PIAugmenting cognitive-behavioral therapy with rTMS of the medial prefrontal and anterior cingulate cortices for the treatment of cocaine use disorder$728.9Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Levin, Frances Rudnick as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2001First NIH AwardPhoenix Pharmalabs, Inc.
- 2001$500K Cumulative Funding
- 2001$1M Cumulative Funding
- 2001Entered Top 50% NationallyRanked #1113
- 2001Entered Top 25% NationallyRanked #1113
- 2001Entered Top 10% NationallyRanked #1113
- 2002$2M Cumulative Funding
- 2002Multi-Institutional ResearchAwards at 2 institutions
- 2003$5M Cumulative Funding
- 2004Program/Center Grant Leader
- 2022$10M Cumulative Funding